UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Outcomes of surgical management of bowel obstruction in relapsed epithelial ovarian cancer (EOC)

Gynecologic oncology, 2012-04, Vol.125 (1), p.31-36

2012

Volltextzugriff (PDF)

Assessing the impact of evolving evidence in renal cell carcinoma treatment: An update of the Renal Cell Carcinoma Appropriateness-based Treatment Toolkit (ReCATT)

European journal of cancer (1990), 2014-12, Vol.50 (18), p.3153-3160

2014

Volltextzugriff (PDF)

Evaluation of treatment options for patients with advanced renal cell carcinoma: Assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodology

European journal of cancer (1990), 2012-05, Vol.48 (7), p.1038-1047

2012

Volltextzugriff (PDF)

Adjuvant Interferon Therapy for Patients at High Risk for Recurrent Melanoma: An Updated Systematic Review

Clinical oncology (Royal College of Radiologists (Great Britain)), 2012-08, Vol.24 (6), p.410-412

2012

Volltextzugriff (PDF)

Primary Excision Margins and Sentinel Lymph Node Biopsy in Clinically Node-negative Melanoma of the Trunk or Extremities

Clinical oncology (Royal College of Radiologists (Great Britain)), 2011-11, Vol.23 (9), p.569-571

2011

Volltextzugriff (PDF)

Epirubicin, Cisplatin and Protracted Venous Infusion 5-Fluorouracil Chemotherapy for Advanced Salivary Adenoid Cystic Carcinoma

Clinical oncology (Royal College of Radiologists (Great Britain)), 2009-05, Vol.21 (4), p.311-314

2009

Volltextzugriff (PDF)

A feasibility study of sequential doublet chemotherapy comprising carboplatin–doxorubicin and carboplatin–paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma

Annals of oncology, 2009-11, Vol.20 (11), p.1787-1793

2009

Volltextzugriff (PDF)

Mucinous ovarian cancer

International journal of gynecological cancer, 2008-03, Vol.18 (2), p.209-214

2008

Volltextzugriff (PDF)

Temsirolimus in the treatment of advanced renal cell carcinoma

Annals of oncology, 2007-07, Vol.18 (suppl-9), p.ix87-ix88

Gore, ME

2007

Volltextzugriff (PDF)

Caelyx®: phase II studies in ovarian cancer

European journal of cancer (1990), 2001-12, Vol.37, p.8-14

2001

Volltextzugriff (PDF)

Neoadjuvant chemotherapy for locally advanced cervical cancer

European journal of cancer (1990), 2003-11, Vol.39 (17), p.2419-2421

2003

Volltextzugriff (PDF)

Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds

Gynecologic oncology, 1990-02, Vol.36 (2), p.207-211

1990

Volltextzugriff (PDF)

A phase II trial of ZD0473 in platinum-pretreated ovarian cancer

European journal of cancer (1990), 2002-12, Vol.38 (18), p.2416-2420

2002

Volltextzugriff (PDF)

Attitudes to chemotherapy in patients with ovarian cancer

Gynecologic oncology, 2004-08, Vol.94 (2), p.427-435

2004

Volltextzugriff (PDF)

The MRC Randomised-controlled Trial of Interferon-α, Interleukin-2 and 5-Fluorouracil vs Interferon-α Alone in Patients with Advanced Renal cell Carcinoma (RE04): Rationale and Progress

Clinical oncology (Royal College of Radiologists (Great Britain)), 2005-08, Vol.17 (5), p.319-321

2005

Volltextzugriff (PDF)

Mucosal Malignant Melanoma of the Head and Neck: the Marsden Experience over Half a Century

Clinical oncology (Royal College of Radiologists (Great Britain)), 2003-06, Vol.15 (4), p.199-204

2003

Volltextzugriff (PDF)

A new standard of care for treatment of ovarian cancer

European journal of cancer (1990), 2000, Vol.36 (1), p.10-12

2000

Volltextzugriff (PDF)

Cisplatin and 5-fluorouracil for symptom control in advanced salivary adenoid cystic carcinoma

Oral oncology, 1997-07, Vol.33 (4), p.275-278

1997

Volltextzugriff (PDF)

Results of ZD0473 in platinum-pretreated ovarian cancer: analysis according to platinum free interval

European journal of cancer (1990), 2002-12, Vol.38, p.S7-S12

2002

Volltextzugriff (PDF)

Carcinosarcoma of the ovary: Incidence, prognosis, treatment and survival of patients

Annals of oncology, 1995-10, Vol.6 (8), p.755-758

1995

Volltextzugriff (PDF)

New approaches to the systemic treatment of melanoma

Cancer treatment reviews, 1999-10, Vol.25 (5), p.259-270

1999

Volltextzugriff (PDF)

Phase I study of carboplatin, doxorubicin and weekly paclitaxel in patients with advanced ovarian carcinoma

Annals of oncology, 2003-04, Vol.14 (4), p.638-642

2003

Volltextzugriff (PDF)

Combining platinum, paclitaxel and anthracycline in patients with advanced gynaecological malignancy

European journal of cancer (1990), 2000-03, Vol.36 (4), p.503-507

2000

Volltextzugriff (PDF)

A matched control study of familial epithelial ovarian cancer: Patient characteristics, response to chemotherapy and outcome

Annals of oncology, 1995-01, Vol.6 (1), p.80-82

1995

Volltextzugriff (PDF)

GM-CSF with biochemotherapy (cisplatin, DTIC, tamoxifen, IL-2 and interferon-alpha): A phase I trial in melanoma

Annals of oncology, 2000-09, Vol.11 (9), p.1183-1189

2000

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(37)
Science & Technology
(37)
Humans
(36)
Female
(28)
Adult
(22)
Biological And Medical Sciences
(22)
Medical Sciences
(22)
Middle Aged
(22)
Aged
(18)
Pharmacology. Drug Treatments
(15)
Antineoplastic Agents
(13)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(13)
Chemotherapy
(13)
Male
(12)
Tumors
(11)
Treatment Outcome
(10)
Ovarian Neoplasms - Drug Therapy
(9)
Ovarian Cancer
(8)
Antineoplastic Agents - Therapeutic Use
(7)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Outcomes of surgical management of bowel obstruction in relapsed epithelial ovarian cancer (EOC)

Assessing the impact of evolving evidence in renal cell carcinoma treatment: An update of the Renal Cell Carcinoma Appropriateness-based Treatment Toolkit (ReCATT)

Evaluation of treatment options for patients with advanced renal cell carcinoma: Assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodology

Adjuvant Interferon Therapy for Patients at High Risk for Recurrent Melanoma: An Updated Systematic Review

Primary Excision Margins and Sentinel Lymph Node Biopsy in Clinically Node-negative Melanoma of the Trunk or Extremities

Epirubicin, Cisplatin and Protracted Venous Infusion 5-Fluorouracil Chemotherapy for Advanced Salivary Adenoid Cystic Carcinoma

A feasibility study of sequential doublet chemotherapy comprising carboplatin–doxorubicin and carboplatin–paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma

Mucinous ovarian cancer

Temsirolimus in the treatment of advanced renal cell carcinoma

Caelyx®: phase II studies in ovarian cancer

Neoadjuvant chemotherapy for locally advanced cervical cancer

Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds

A phase II trial of ZD0473 in platinum-pretreated ovarian cancer

Attitudes to chemotherapy in patients with ovarian cancer

The MRC Randomised-controlled Trial of Interferon-α, Interleukin-2 and 5-Fluorouracil vs Interferon-α Alone in Patients with Advanced Renal cell Carcinoma (RE04): Rationale and Progress

Mucosal Malignant Melanoma of the Head and Neck: the Marsden Experience over Half a Century

A new standard of care for treatment of ovarian cancer

Cisplatin and 5-fluorouracil for symptom control in advanced salivary adenoid cystic carcinoma

Results of ZD0473 in platinum-pretreated ovarian cancer: analysis according to platinum free interval

Carcinosarcoma of the ovary: Incidence, prognosis, treatment and survival of patients

New approaches to the systemic treatment of melanoma

Phase I study of carboplatin, doxorubicin and weekly paclitaxel in patients with advanced ovarian carcinoma

Combining platinum, paclitaxel and anthracycline in patients with advanced gynaecological malignancy

A matched control study of familial epithelial ovarian cancer: Patient characteristics, response to chemotherapy and outcome

GM-CSF with biochemotherapy (cisplatin, DTIC, tamoxifen, IL-2 and interferon-alpha): A phase I trial in melanoma

Aktive Filter

Suchergebnisse filtern